[Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
Broedl
U C
UC
Medizinische Klinik und Poliklinik II, Campus Grosshadern, München. uli.broedl@med.uni-muenchen.de
Lehrke
M
M
Parhofer
K G
KG
D002318:Cardiovascular Diseases / Q000097:blood / Q000517:prevention & control; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D048909:Diabetes Complications / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D008019:Life Style; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications; D012016:Reference Values; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D014280:Triglycerides